Hydroxyethyl starch or saline in intensive care [3]

New England Journal of Medicine

Volumn 368, Issue 8, 2013, Pages 774-775

  Guidet, Bertrand ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; SODIUM CHLORIDE; CHLORIDE; RINGER ACETATE;

DISEASE SEVERITY; FLUID RESUSCITATION; FLUID THERAPY; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY INJURY; LETTER; MEDICAL ERROR; MOLECULAR WEIGHT; PATIENT SAFETY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEPTIC SHOCK; TREATMENT OUTCOME; CRITICAL ILLNESS; FEMALE; MALE; METHODOLOGY; NOTE; ACUTE KIDNEY FAILURE; CIRCULATION; CRYSTALLOID VERSUS HYDROXYETHYL STARCH TRIAL; HEALTH HAZARD; MORTALITY; TYPES OF STUDY;

CRITICAL ILLNESS; FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; MALE;

EID: 84874003609     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1215977     Document Type: Letter

References (3)

1. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.
2. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34. [Erratum, N Engl J Med 2012;367:481.]
3. Guidet B, Martinet O, Boulain T, et al. Assessment of haemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012;16(3):R94.